FDA Concludes Probe of Agency Selling Embryos
This article is from the archive of The New York Sun before the launch of its new website in 2022. The Sun has neither altered nor updated such articles but will seek to correct any errors, mis-categorizations or other problems introduced during transfer.
SAN ANTONIO — The Food and Drug Administration has ended an investigation into a broker offering ready-made embryos to prospective parents.
The FDA has not disclosed what laws or regulations were the focus of the investigation into Jennalee Ryan’s Abraham Center of Life. The agency’s statement yesterday said “the investigation determined the facility was not currently engaged in practices that fall under FDA jurisdiction.”
Ms. Ryan’s service involves a physician who uses donated eggs and sperm to create embryos that cost $5,000 a pair. Clients can review the donors’ characteristics, including their ethnic and educational background and, in some cases, their photos.
